Cutler Group LP Atai Life Sciences N.V. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.03 - $5.32 $2,121 - $3,724	-700 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$4.66 - $7.66 $932 - $1,532	-200 Reduced 22.22%	700 $3,000
Q4 2021 Jan 18, 2022	SELL	$6.82 - $17.8 $2,046 - $5,340	-300 Reduced 25.0%	900 $6,000
Q2 2021 Jul 19, 2021	BUY	$16.94 - $19.89 $20,328 - $23,868	1,200 New	1,200 $22,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $189M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.